JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2010, 59(2):59-66

A study of the compaction process and the properties of tablets from two types of directly compressible sorbitol

J. Mužíková*, E. Zemanová
Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Department of Pharmaceutical Technology, Czech Republic

The paper deals with the study of energy conditions in the course of compaction and the properties of tablets from two types of the directly compressible sorbitol Sorbitab™ SD 250 and Sorbitab™ SD 500. The tested properties included tensile strength of tablets and disintegration time of tablets, examined in dependence on compression force, addition of two types of lubricants in two concentrations, and two types of active ingredients in one concentration. A comparison of both types of directly compressible sorbitol revealed that the negative moment in the use of Sorbitab SD 500 is the effect of the presence of lubricants on the strength of the compacts, and furthermore a more significant prolongation of disintegration time of tablets by the action of lubricants in contrast to Sorbitab SD 250. The energy balance of compression showed a higher value of total energy of compression for Sorbitab SD 500 due to higher values of energy required for friction and the energy accumulated by the tablet.

Keywords: directly compressible sorbitol; lubricants; tensile strength of tablets; disintegration time; force-displacement profile
Grants and funding:

The study was supported by the grant MSM 0021620822 and by the firm SPI Pharma, which supplied the samples of the dry binders tested.

Received: February 16, 2009; Accepted: March 15, 2010; Published: February 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Mužíková J, Zemanová E. A study of the compaction process and the properties of tablets from two types of directly compressible sorbitol. Čes. slov. farm. 2010;59(2):59-66.
Download citation

References

  1. Kibbe, A. H.: Handbook of pharmaceutical excipients. 3rd Ed. London: APhA Washington and PhP 2000; 515-518.
  2. Bolhuis, G. K., Chowhan, Z. T.: Materials for direct compaction. In Alderborn, G, Nystrőm, Ch. (eds.) Pharmaceutical Powder Compaction Technology, Inc. New York: Marcel Dekker 1996, 419-500. Go to original source...
  3. Du Ross, J. W.: Modification of the crystalline structure of sorbitol and its effect on tableting characteristics. Pharm. Technol., 1984; 8, 42-53.
  4. Schangraw, R. F., Wallace, J. W., Bowers F. M.: Morphology and functionality in tablet excipients for direct compression: part I. Pharm. Technol., 1981; 5, 69-78.
  5. Guyot-Hermann, A.M., Leblanc, D., Draguet-Brughmans, M.: Gamma sorbitol as a diluent in tablets. Drug Dev. Ind. Pharm., 1985; 11, 551-564. Go to original source...
  6. Schmidt, P. C.: Tableting characteristics of sorbitol. Pharm. Technol., 1983; 7, 65-74.
  7. SPI Pharma: Sorbitab™ SD 250 and Sorbitab™ SD 500 Spray Dried Sorbitol. Fir.Lit., Web: http://www.spipharma.com/ProductsFolder/SD250_SD500/SD250_SD500.html (2. 11. 2007).
  8. Ragnarsson, G.: Force-displacement and network measurements. In Alderborn, G@ Nystrőm, Ch., eds. Pharmaceutical Powder Compaction Technology, Inc. NeyYork: Marcel Dekker 1996, 77-132. Go to original source...
  9. Fell, J. T., Newton, J. M.: Determination of tablet strength by diametral-compression test.J. Pharm. Sci., 1970; 59, 688-691. Go to original source... Go to PubMed...
  10. Bos, C. E., Bolhuis, H., Van Doorne, Lerk, C. F.: Native starch in tablet formulations: Properties on compaction. Pharm. Weekbl. 1987; Sci. Ed. 9, 274-282.
  11. Belousov, V. A.: K voprosu o vybore optimalnikh davlenii pressovania pri tabletirovanii lekarstvennykh poroshkov. Khim. Farm. Zh., 1976; 10, 105-111.
  12. Jarosz, P. J., Parrot, E. L.: Effect of lubricants on tensile strengths of tablets. Drug Dev. Ind. Pharm., 1984; 10, 259-273. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.